StockNews.com initiated coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a sell rating on the medical research ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in ...

Asia Pacific 3D Printers market will grow by 24.2% annually with a total addressable market cap of $83,125.4 million over 2023-2030, driven by enhancing efficiencies in manufacturing, improvement in ...

Europe 3D printing was valued at $4,451.9 million in 2022 and will grow by 23.1% annually over 2022-2030, driven by the enhancing efficiencies in manufacturing, improvement in terms of cost and time, ...

Organovo Holdings, Inc. (Nasdaq: NASDAQ:ONVO) today announced the presentation of preclinical data related to the company’s FXR314 development program in its proprietary 3D human ...